Breaking News

Sartorius Stedim Biotech Expands PAT Software Portfolio

December 18, 2012

To market Umetrics chemometrics software

Sartorius Stedim Biotech (SSB) has entered into a global sales partnership with Umetrics AB, a provider of chemometrics software for modeling and optimizing development and manufacturing processes. SSB will assume global marketing and distribution of Umetrics portfolio for the pharma and biopharma industries. Additionally, SSB will integrate Umetrics software programs as private label products into its own bioprocess portfolio and market the stand-alone solutions under both brands.
 
Stefan Schlack, senior vice president of marketing at SSB, said, “These software solutions will help our customers to better understand their cell culture processes and to identify potential for optimization and robust process control — an ideal addition to our bioprocess portfolio.”
 
“With SSB, we can gain access to substantially more customers thanks to its international reach and solid market standing in the biopharma sector. SSB’s integrated solutions for the complete biopharmaceutical process clearly create added value for our customers. I anticipate that this will considerably boost the biopharmaceutical industry’s interest in and usage of our products,” said Lars Lindstorm, general manager of Umetrics.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks